Connectus Wealth, LLC Biomarin Pharmaceutical Inc Transaction History
Connectus Wealth, LLC
- $4.37 Billion
- Q1 2024
A detailed history of Connectus Wealth, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Connectus Wealth, LLC holds 3,011 shares of BMRN stock, worth $167,321. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,011
Previous 3,011
-0.0%
Holding current value
$167,321
Previous $290,000
9.66%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
675Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.06 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$876 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$840 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$683 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...